评估和管理化疗引起的周围神经病理性疼痛的机制、预测因素和挑战。
Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.
机构信息
School of Nursing, University of Michigan, Ann Arbor, MI.
Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA.
出版信息
Semin Oncol Nurs. 2019 Jun;35(3):253-260. doi: 10.1016/j.soncn.2019.04.006. Epub 2019 Apr 30.
Abstract
OBJECTIVE
To describe the known predictors and pathophysiological mechanisms of chronic painful chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors and the challenges in assessing and managing it.
DATA SOURCES
PubMed/Medline, CINAHL, Scopus, and PsycINFO.
CONCLUSION
The research on chronic painful CIPN is limited. Additional research is needed to identify the predictors and pathophysiological mechanisms of chronic painful CIPN to inform the development of assessment tools and management options for this painful and possibly debilitating condition.
IMPLICATIONS FOR NURSING PRACTICE
Recognition of the predictors of chronic painful CIPN and proactive CIPN assessment and palliative management are important steps in reducing its impact on physical function and quality of life.
摘要
目的
描述癌症幸存者慢性痛性化疗诱导周围神经病（CIPN）的已知预测因素和病理生理机制，以及评估和管理该疾病所面临的挑战。
资料来源
PubMed/Medline、CINAHL、Scopus 和 PsycINFO。
结论
慢性痛性 CIPN 的研究有限。需要开展更多研究以确定慢性痛性 CIPN 的预测因素和病理生理机制，为开发评估工具和管理方案提供信息，以改善这一痛苦且可能使人衰弱的病症。
意义
认识慢性痛性 CIPN 的预测因素，主动进行 CIPN 评估和姑息治疗管理，是减轻其对身体功能和生活质量影响的重要步骤。
相似文献
1
Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.
Semin Oncol Nurs. 2019 Jun;35(3):253-260. doi: 10.1016/j.soncn.2019.04.006. Epub 2019 Apr 30.
2
Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
Support Care Cancer. 2020 Dec;28(12):5933-5941. doi: 10.1007/s00520-020-05438-5. Epub 2020 Apr 12.
3
Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review.
Br J Anaesth. 2017 Oct 1;119(4):737-749. doi: 10.1093/bja/aex229.
4
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
Eur J Cancer Care (Engl). 2017 Mar;26(2). doi: 10.1111/ecc.12421. Epub 2015 Nov 25.
5
Chemotherapy-induced peripheral neuropathy: an algorithm to guide nursing management.
Clin J Oncol Nurs. 2013 Apr;17(2):138-44. doi: 10.1188/13.CJON.138-144.
6
Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
J Pain Palliat Care Pharmacother. 2020 Sep;34(3):141-152. doi: 10.1080/15360288.2020.1734144. Epub 2020 Mar 2.
7
Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
Pain Physician. 2018 Nov;21(6):571-592.
8
Neuroimaging reveals a potential brain-based pre-existing mechanism that confers vulnerability to development of chronic painful chemotherapy-induced peripheral neuropathy.
Br J Anaesth. 2023 Jan;130(1):83-93. doi: 10.1016/j.bja.2022.09.026. Epub 2022 Nov 14.
9
Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.
Pain. 2016 Mar;157(3):560-568. doi: 10.1097/j.pain.0000000000000404.
10
Recent advances in understanding chemotherapy-induced peripheral neuropathy.
F1000Res. 2020 Mar 11;9. doi: 10.12688/f1000research.21625.1. eCollection 2020.
引用本文的文献
1
5,7-Dimethoxycoumarin ameliorates vincristine induced neuropathic pain: potential role of 5HT receptors and monoamines.
Front Pharmacol. 2023 Oct 17;14:1213763. doi: 10.3389/fphar.2023.1213763. eCollection 2023.
2
Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study.
J Foot Ankle Res. 2023 Aug 21;16(1):52. doi: 10.1186/s13047-023-00650-y.
3
Predictors of Nurse Practitioner Prescription of Opioids for Cancer Pain: Quantitative Results.
J Adv Pract Oncol. 2023 Jan;14(1):22-35. doi: 10.6004/jadpro.2023.14.1.2. Epub 2023 Feb 1.
4
Generation of Human Nociceptor-Enriched Sensory Neurons for the Study of Pain-Related Dysfunctions.
Stem Cells Transl Med. 2022 Jul 20;11(7):727-741. doi: 10.1093/stcltm/szac031.
5
Routine Cancer Treatment Regimens and Its Impact on Fine Motor Dexterity in Breast Cancer.
Oncol Res Treat. 2022;45(1-2):37-44. doi: 10.1159/000519829. Epub 2021 Oct 13.
6
Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy.
Int J Mol Sci. 2021 Aug 26;22(17):9257. doi: 10.3390/ijms22179257.
7
Is Neuropathic Pain a Good Marker of Peripheral Neuropathy in Hospice Patients with Advanced Cancer? The Single Center Pilot Study.
Diagnostics (Basel). 2021 Jul 30;11(8):1377. doi: 10.3390/diagnostics11081377.
8
Exploring the relationship among dispositional optimism, health-related quality of life, and CIPN severity among colorectal cancer patients with chronic peripheral neuropathy.
Support Care Cancer. 2022 Jan;30(1):95-104. doi: 10.1007/s00520-021-06352-0. Epub 2021 Jul 7.
9
Physiotherapy for people with painful peripheral neuropathies: a narrative review of its efficacy and safety.
Pain Rep. 2020 Sep 23;5(5):e834. doi: 10.1097/PR9.0000000000000834. eCollection 2020 Sep-Oct.
本文引用的文献
1
The Burden of Opioid-Related Mortality in the United States.
JAMA Netw Open. 2018 Jun 1;1(2):e180217. doi: 10.1001/jamanetworkopen.2018.0217.
2
A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer.
Gynecol Oncol. 2019 Feb;152(2):310-315. doi: 10.1016/j.ygyno.2018.12.002. Epub 2018 Dec 14.
3
Cold therapy to prevent paclitaxel-induced peripheral neuropathy.
Support Care Cancer. 2018 Oct;26(10):3461-3469. doi: 10.1007/s00520-018-4199-9. Epub 2018 Apr 21.
4
Estimating the Frequency, Severity, and Clustering of SPADE Symptoms in Chronic Painful Chemotherapy-Induced Peripheral Neuropathy.
Pain Manag Nurs. 2018 Aug;19(4):354-365. doi: 10.1016/j.pmn.2018.01.001.
5
In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.
Cancer Control. 2018 Jan-Mar;25(1):1073274818756608. doi: 10.1177/1073274818756608.
6
Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia.
Eur J Paediatr Neurol. 2018 May;22(3):457-469. doi: 10.1016/j.ejpn.2017.12.019. Epub 2018 Jan 5.
7
Medical Cannabis for Neuropathic Pain.
Curr Pain Headache Rep. 2018 Feb 1;22(1):8. doi: 10.1007/s11916-018-0658-8.
8
Anatomical evidence for lateral hypothalamic innervation of the pontine A7 catecholamine cell group in rat.
Neurosci Lett. 2018 Mar 6;668:80-85. doi: 10.1016/j.neulet.2018.01.016. Epub 2018 Jan 9.
9
Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Multicenter, Pilot, Randomized, Wait-List Controlled Trial.
J Pain. 2018 Apr;19(4):382-394. doi: 10.1016/j.jpain.2017.11.009. Epub 2017 Dec 8.
10
Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review.
Crit Rev Oncol Hematol. 2018 Jan;121:90-100. doi: 10.1016/j.critrevonc.2017.11.002. Epub 2017 Nov 7.
Zotero 插件